AltheRx

AltheRx Pharmaceuticals is a privately held clinical development company dedicated to advancing first-in-class compounds with high potential in large unmet markets. The company focuses on clinical development and optimizes commercialization through partnerships. The name AltheRx is derived from Althea, the Greek goddess of healing. The company’s lead product, Solabegron, is a highly differentiated new compound under investigation for OAB and IBS, conditions that impact the quality of life for over 90 million Americans, a number that is increasing significantly with the aging population.